Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

ABIVAX Société Anonyme (AAVXF)

5.81
0.00
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cost of Revenue
--
--
--
50,764
45,517
Gross Profit
--
--
--
-50,764
-45,517
Operating Expense
172,984
172,984
127,377
51,205
41,398
Operating Income
-172,984
-172,984
-127,377
-51,205
-41,398
Net Non Operating Interest Income Expense
-4,564
-4,564
-12,708
-6,717
-3,476
Other Income Expense
1,307
1,307
-7,654
-2,820
2,425
Pretax Income
-176,242
-176,242
-147,740
-60,740
-42,452
Net Income Common Stockholders
-176,242
-176,242
-147,740
-60,740
-42,452
Diluted NI Available to Com Stockholders
-176,242
-176,242
-147,740
-60,740
-42,452
Basic EPS
-3.43
-2.80
-3.43
-3.18
-2.75
Diluted EPS
-3.43
-2.80
-3.43
-3.18
-2.75
Basic Average Shares
43,066.01
63,046.35
43,066.01
19,092.44
15,455.99
Diluted Average Shares
43,066.01
63,046.35
43,066.01
19,092.44
15,455.99
Total Operating Income as Reported
-172,984
-172,984
-127,376
-64,836
-41,400
Rent Expense Supplemental
482
--
--
1,048
548
Total Expenses
172,984
172,984
127,377
51,205
41,398
Net Income from Continuing & Discontinued Operation
-176,242
-176,242
-147,740
-60,740
-42,452
Normalized Income
-177,549
-177,549
-140,086
-57,920
-44,877
Interest Income
8,956
8,956
2,773
--
--
Interest Expense
12,431
12,431
13,826
6,940
3,558
Net Interest Income
-4,564
-4,564
-12,708
-6,717
-3,476
EBIT
-163,811
-163,811
-133,914
-53,800
-38,894
EBITDA
-162,711
-162,711
-133,207
-53,315
-38,592
Reconciled Cost of Revenue
--
--
--
50,526
45,517
Reconciled Depreciation
1,100
1,100
707
485
302
Net Income from Continuing Operation Net Minority Interest
-176,242
-176,242
-147,740
-60,740
-42,452
Total Unusual Items Excluding Goodwill
1,307
1,307
-7,654
-2,820
2,425
Total Unusual Items
1,307
1,307
-7,654
-2,820
2,425
Normalized EBITDA
-164,018
-164,018
-125,553
-50,495
-41,017
12/31/2021 - 9/27/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DBV.F DBV Technologies S.A.
1.4900
+11.36%
 
GLPG.VI Galapagos NV
22.54
+0.54%
 
ALCOX.PA Nicox S.A.
0.2260
0.00%
 
GNFT.PA Genfit S.A.
3.2240
+1.45%
 
GNFT Genfit S.A.
3.6700
-2.65%
 
DBV.PA DBV Technologies S.A.
1.5440
+5.46%
 
ITOS iTeos Therapeutics, Inc.
7.46
+4.34%
 
GLPG Galapagos NV
26.49
+3.88%
 
DBVT DBV Technologies S.A.
8.90
-3.89%
 
NMRA Neumora Therapeutics, Inc.
0.7495
+5.43%